Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
626 dias atrás
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
892 dias atrás
Swiss Market Ends Moderately Lower
After a positive start and a subsequent mild setback, the Switzerland market recovered and stayed firm till a little past mid afternoon on Thursday, but turned weak and ended the day's session moderately lower.
Investors digested the monetary policy moves of the Federal Reserve and the Bank of England, and reports about the U.S. and the U.K. striking a trade deal.
RTTNews
|
1h 6min atrás
European Stocks Close On Firm Note On Easing Trade Tensions
European stocks closed on a firm note on Thursday with investors reacting to earnings, and news about an impending trade deal between the U.S. and the U.K., and digesting the Bank of England and the Federal Reserve's monetary policy moves.
RTTNews
|
1h 26min atrás
Canadian Market Firmly Higher; Energy, Consumer Discretionary Stocks Rise
The Canadian market is firmly placed in positive territory a little past noon on Thursday with stocks from energy, communications, healthcare and consumer discretionary sectors contributing to the upmove.
RTTNews
|
2h 7min atrás
U.S. Wholesale Inventories Climb Slightly Less Than Expected In March
The Commerce Department released a report on Thursday showing wholesale inventories in U.S. increased by slightly less than expected in the month of March. The report said wholesale inventories rose by 0.4 percent in March after climbing by an upwardly revised 0.5 percent in February.
RTTNews
|
3h 46min atrás
U.S. Labor Productivity Decreases For First Time Since 2022
The Labor Department released a report on Thursday showing a pullback by U.S. labor productivity in the first quarter of 2025 along with a sharp increase by unit labor costs. The report said labor productivity fell by 0.8 percent in the first quarter after jumping by an upwardly revised 1.7 percent in the fourth quarter of 2024.
RTTNews
|
4h 20min atrás
U.S. Weekly Jobless Claims Dip Slightly More Than Expected
First-time claims for U.S. unemployment benefits saw a modest decline in the week ended May 3rd, according to a report released by the Labor Department on Thursday. The report said initial jobless claims dipped to 228,000, a decrease of 13,000 from the previous week's unrevised level of 241,000. Economists had expected jobless claims to slip to 230,000.
RTTNews
|
4h 26min atrás
